A recently released study funded by the German-Israeli Foundation helped scientists find what may be a link between obesity, nephropathy and kidney disease.
Parkinson’s patients report long-term therapeutic benefits from the daily use of medical cannabis, according to the journal Clinical Neuropharmacology.
He built a career as chief financial officer for two different firms and as a consultant for forensic accounting. He is now fighting multiple sclerosis.
Could cannabis be the new, improved answer for patients suffering from spasticity? The roughly 12 million people worldwide who are thought to suffer from the condition would love to hear that news.